Healthcare is the hottest area for investment in AI, with 270 deals made since 2012. With an aging population, increasing demand and rising drug costs, many areas within the industry are changing and AI is making unimaginable innovation possible. In 2012, robots started winning competitions when it came to screening cancer with deep neural networks. Beyond disease diagnosis, AI is also speeding up drug discovery processes, improving clinical trial efficiency, personalising treatment plans and improving access to affordable healthcare. However, to deliver Machine Learning optimisation, the industry must collect end-to-end patient journey data such as initial diagnosis through to treatment outcomes. Will AI ultimately enable a better quality of life?